Skip to content

Feasibility of Passive Data Collection in Dementia Subjects With Agitation

A Feasibility Study to Evaluate Passive Collection of Activity Data in Subjects With Agitation in the Context of Dementia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04413851
Enrollment
1
Registered
2020-06-04
Start date
2020-06-01
Completion date
2021-12-06
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Dementia, Frontotemporal Dementia, Lewy Body Dementia, Mixed Dementia, Vascular Dementia

Brief summary

This is a multi-center, observational, feasibility study, to evaluate long term passive data collection, data quality, and user experience of HealthMode Agitation (Apps) to collect motion, location, physiological, and audio data; and eCOA and EMA responses with mobile devices (iPhone, Apple Watch). The purpose of this study is to evaluate and improve HealthMode Apps data collection and usability in subjects experiencing agitation in the context of dementia.

Interventions

None listed

Sponsors

HealthMode Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female subjects 18 years and older. * Subjects who have met DSM-5 criteria for Dementia (all cause) * Subjects with a recent history of agitation in the past 6 months to a point that impairs social activities, requires staffing or medical intervention (kick, bite, flailing, etc.), impairs ability for functional activities of daily living, as disclosed by a caregiver or documented in the medical record. * Subjects resident in a group home, nursing home, or assisted living are eligible to participate. * Subjects who can read, understand and provide written informed consent or who have a Legally Acceptable Representative (LAR) * Subjects who are willing and able to carry a smartphone and wear an activity tracker on their wrist or hand, alone or with the help of a caregiver. * Subjects who, either alone or with a caregiver, are able to operate a smartphone and wrist or hand-worn activity tracker, alone or with the help of a caregiver. * Subjects who are in good general health prior to study participation as determined by a detailed medical history, and in the opinion of the Principal Investigator. * Subjects, who are able to ambulate without an assistive device, or with a single point cane.

Exclusion criteria

* Subjects who are unwilling or unable to carry a smartphone and wear an activity tracker on their wrist or hand. * Subjects with serious or unstable medical illnesses. These include current hepatic (moderate-severe hepatic impairment), renal, gastroenterological, respiratory, cardiovascular (including ischemic heart disease, congestive heart failure), endocrinologic, neurologic or hematologic disease. * Subjects who are considered by the investigator, for any reason, to be an unsuitable candidate.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of passive and continuous data collection28 daysTotal time and percentage of continuous data collection for each stream of data aiming for \>50% coverage.

Secondary

MeasureTime frameDescription
Tolerability of carrying a smartphone and wearing a data collection sensor on the wrist and/or hand in a population of subjects who may have frequent episodes of agitation or impulsive behavior.28 daysCaregiver and Staff engagement with the eCOA and EMA (threshold 80% completion) and responses to usability questionnaires at week 1 and 4 to provide feedback on comfort, usability and engagement. The score ranges from 10 to 50, higher score indicating a better usability.

Other

MeasureTime frameDescription
Suitability of individual data streams and their combinations for purposes of identification of agitation episodes in passively collected data.28 daysComparison of data collected from the smartphone and wearable device to episodes identified by subject or caregiver assessment: 1. Cleaned single channel data compared to assessments 2. Cleaned multichannel data compared to assessments 3. Analyzed multichannel data compared to assessments 4. Subject/Caregiver assessment data compared to agitation scale ratings 5. Agitation scale ratings compared to cleaned single and multichannel data and analyzed multichannel data. 6. Merged subject/caregiver assessment and multichannel data compared to agitation scale ratings

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026